l-carnitine tmao nature medicine 2013 koeth γ–Butyrobetaine is a pro-atherogenic intermediate in gut microbial metabolism of to Trimethylamine/Trimethylamine-N-Oxide as a Key Between
Trimethylamine Trimethylamine N Oxide as a Key Between Diet and Cardiovascular Diseases Cardiovascular Toxicology Springer Nature Link Effects of choline metabolitetrimethylamine N oxide on immunometabolism in inflammatory bowel disease Frontiers Characterization of TMAO productivity from carnitine challenge facilitates personalized nutrition and microbiome signatures discovery Microbiome Springer Nature Link Trimethylamine Noxide: breathe new life Subramaniam 2018 British Journal of Pharmacology Wiley Online Library Gut Microbiota Derived TMAO: A Causal Factor Promoting Atherosclerotic Cardiovascular Disease? Gut Derived Metabolite, Trimethylamine N oxide (TMAO) in Cardio Metabolic Diseases: Detection, Mechanism, and Potential Therapeutics
Pay in 4 interest-free payments of $7.33 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12





